Posts

Showing posts with the label Heather Bresch

Readers Choice

Navigating the Unknown: Leadership in an Era of Uncertainty

Image
 Leading through the mists of uncertainty can feel formidable; yet, it unveils a chance to display resilience, adaptability, and visionary leadership. Here are a tapestry of strategies to amplify your prowess in traversing unpredictable realms: Embrace Flexibility and Adaptability Stay Agile: Nurture a malleable work atmosphere that empowers teams to swiftly shift and respond to emerging insights and changing tides. Iterative Planning: Break down long-term visions into smaller, manageable milestones that can be recalibrated as needed, allowing for continual reassessment and evolution. Communicate Transparently Honest Updates: Keep your team apprised of the current landscape, even when the news is less than favorable. Transparency begets trust and ensures collective alignment. Open Dialogue: Foster a space where team members feel emboldened to express their concerns and ideas, enriching insights and uplifting morale. Focus on What You Can Control Identify Priorities: Direct your ene...

"India has a lot to offer both in innovation and operation"

Image
Mylan CEO Heather Bresch speaks to BT's P.B. Jayakumar on how the generic pharma sector is consolidating globally and Mylan's role in leading the transition from the front. Mylan CEO Heather Bresch If Mylan CEO Heather Bresch manages to complete the $27.1 billion hostile takeover of Ireland-based rival Perrigo, it would perhaps be her most valued acquisition and help her position the $7.72 billion generic and specialty pharmaceuticals company as one of the top three global generic pharma players. But then, successfully thwarting a similar attempt by another rival, Teva Pharmaceuticals, to acquire Mylan for $40 billion barely two months ago on July 23, was no mean deed either. In fact, the 46-year-old has been making history ever since she joined Mylan as a clerk in 1992, steadily rising up the ranks to serve as the companys chief operating officer, chief integration officer and president, before taking over as the first ever woman chief executive of a global pharma majo...